Redmile Group’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-231,595
Closed -$31.9M 78
2023
Q1
$31.9M Buy
+231,595
New +$31.9M 1.39% 25
2019
Q3
Sell
-412,000
Closed -$62.6M 80
2019
Q2
$62.6M Buy
+412,000
New +$62.6M 1.77% 19
2018
Q3
Sell
-31,100
Closed -$4.11M 93
2018
Q2
$4.11M Buy
+31,100
New +$4.11M 0.14% 62
2016
Q4
Sell
-640,400
Closed -$39.3M 58
2016
Q3
$39.3M Buy
+640,400
New +$39.3M 3.13% 13